Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption Academic Article uri icon

Overview

MeSH Major

  • Acneiform Eruptions
  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Colorectal Neoplasms
  • Dermatologic Agents
  • Minocycline
  • Nicotinic Acids

abstract

  • Prophylaxis with oral minocycline may be useful in decreasing the severity of the acneiform rash during the first month of cetuximab treatment. Topical tazarotene is not recommended for management of cetuximab-related rash.

publication date

  • December 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2007.12.6987

PubMed ID

  • 18048820

Additional Document Info

start page

  • 5390

end page

  • 6

volume

  • 25

number

  • 34